Literature DB >> 8097763

N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.

J Kornhuber, P Riederer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097763      PMCID: PMC1014969          DOI: 10.1136/jnnp.56.4.427

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

Review 1.  Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.

Authors:  P Riederer; K W Lange; J Kornhuber; W Danielczyk
Journal:  Arzneimittelforschung       Date:  1992-02

2.  Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.

Authors:  J Kornhuber; J Bormann; W Retz; M Hübers; P Riederer
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

3.  Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease.

Authors:  T Klockgether; L Turski
Journal:  Trends Neurosci       Date:  1989-08       Impact factor: 13.837

4.  Controlled trial of amantadine hydrochloride in Parkinson's disease.

Authors:  J D Parkes; D M Calver; K J Zilkha; R P Knill-Jones
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

5.  Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

Authors:  J Kornhuber; J Bormann; M Hübers; K Rusche; P Riederer
Journal:  Eur J Pharmacol       Date:  1991-04-25       Impact factor: 4.432

6.  A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.

Authors:  J L Montastruc; O Rascol; J M Senard; A Rascol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.